We are live on
!
Find out more
VM
Valor Management Portfolio holdings
AUM
$181M
1-Year Est. Return
6.67%
This Fund
S&P 500
This Quarter
Est. Return
+2.74%
1 Year Est. Return
+6.67%
3 Year Est. Return
+15.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$628M
AUM Growth
–
Cap. Flow
+$620M
Cap. Flow
% of AUM
98.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harmony Biosciences
HRMY
|
+$447M |
| 2 |
BRDS
Bird Global, Inc.
BRDS
|
+$161M |
| 3 |
DocGo
DCGO
|
+$9.98M |
| 4 |
Porch Group
PRCH
|
+$2.32M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.81% |
| 2 | Consumer Discretionary | 21.9% |
| 3 | Financials | 0.3% |
Similar funds
AA
MGW
TWP
MPG
BRPW
ATIA
FFA
RWP
Valor Management's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Valor Management, which disclosed 4 positions worth $628M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Harmony Biosciences: 11,218,033 shares worth $478M.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, followed by Consumer Discretionary and Financials.
- Valor Management's largest Q4 2021 buy was Harmony Biosciences: 11,218,033 shares worth $478M.
- Valor Management's ten largest holdings make up 100% of its $628M portfolio in Q4 2021.
- Valor Management disclosed 4 positions in Q4 2021, its first 13F filing on record.
Based on Valor Management's 13F filing for Q4 2021, filed 9 Feb 2022.